Abstract
Introduction

48
Acute respiratory infections account for a large proportion of deaths worldwide 49 [1] . In particular, influenza virus infection is life threatening for elderly individuals and 
66
Moreover, some TLR agonists were recently found to have anti-infective, antitumor, and 67 anti-allergic effects based on their functions as immune activators [11] [12] [13] [14] .
68
UT12 is an antibody generated against BaF3 cells overexpressing mouse TLR4. 
TLR ligands enhances host immunity against influenza virus infection or pneumococcal
74
infection alone [16, 17] . However, no report has verified the effectiveness of the TLR 75 agonist for an influenza virus/bacteria co-infection, which is more lethal than when either 76 pathogen is delivered alone.
77
Therefore, in the present study, we sought to elucidate the mechanistic basis of antibodies for western blotting were purchased from Abcam (Cambridge, UK).
86
Secondary antibodies for western blotting were purchased from Santa Cruz 87 Biotechnology (Santa Cruz, CA, USA). Inhibitors of JNK (SP600125), p38 (SB203580),
88
MEK-1 (PD98059), and NF-κB (parthenolide) were obtained from Sigma-Aldrich Japan
89
(Tokyo, Japan).
91
Mice
92
CBA/JNCrlj mice (6-week-old males) were purchased from Charles River Laboratories 93 Japan (Yokohama, Japan). C3H/HeJ and C3H/HeN mice (6-week-old males) were 94 purchased from Japan SLC (Hamamatsu, Japan All data were expressed as means ± SDs and analyzed by using StatView software
178
(Abacus Concepts, Cary, NC, USA). Survival curves were estimated by the
179
Kaplan-Meier method, and their homogeneity was evaluated by the log-rank test.
180
Differences between 2 groups were tested for significance using unpaired t-tests.
181
Differences between multiple groups were tested for significance using 2-way analysis of 
Results
186
UT12 administration improved survival in co-infected mice
187
Mice co-infected with influenza A virus followed 2 days later by pneumococcus had a 188 higher rate of mortality than mice infected with a single pathogen ( influenza and S. pneumoniae, no significant differences were observed (data not shown).
205
Total cell counts in the BALF were significantly lower in UT12-treated mice than in 206 control mice (P < 0.05). In addition, neutrophil counts were also decreased by UT12 207 treatment, although the difference was not significant (P = 0.10, Fig. 4b ).
208
Robust innate pro-inflammatory cytokine expression can cause direct tissue hypothesized that UT12 might protect a host from severe lung injury by preventing 212 cytokine storms through the reduction of host sensitivity against pneumococcal infection.
213
As shown in Fig. 4c , after co-infection, the levels of TNF-α, IL-6, KC, and MIP-2 were 214 significantly suppressed in UT12-treated mice as compared to control mice (TNF-α: P < 215 0.001, IL-6: P < 0.001, KC: P < 0.01, MIP-2: P < 0.05).
216
Furthermore, we assayed concentrations of NF-κB, a transcription factor that 217 plays critical roles in inflammation, in the lungs of mice co-infected with the 2 pathogens.
218
Excessive activation of NF-κB can induce a cytokine storm, resulting in septic shock [23] .
219
In the current study, the levels of activated NF-κB in the lung homogenates after 220 co-infection were significantly suppressed by UT12 administration (P < 0.05, Fig. 5 ).
221
These data suggested that UT12 might be able to attenuate the expression of cytokines significantly increased compared to that in vehicle-treated mice (P < 0.05, Fig. 8a ).
251
MCP-1 is a chemokine that recruits mononuclear cells to the infectious source.
252
The production of MCP-1 in the lungs was markedly increased after UT12 
259
To confirm the importance of macrophages for protection against pneumococcal 260 infection, we compared survival after S. pneumoniae infection between 261 macrophage-depleted mice and mice with intact macrophages. All macrophage-depleted 262 mice died within 6 days of infection; however, all intact mice survived at least 6 days after 263 pneumococcal infection (P < 0.001, Fig. 9 ). Improved survival mediated by UT12 was 264 not observed in macrophage-depleted mice (Fig. 9) . Taken together, these data indicated 
275
Compared with vehicle-treated mice, UT12 pretreatment significantly increased the 276 levels of activated NF-κB in uninfected mice (P < 0.001; Supplementary Fig. 1 ). In 277 addition, the level of phosphorylated JNK was also clearly increased at 2 h after UT12 278 administration (Fig. 10a) , whereas the levels of phosphorylated p38 and MEK-1 were involved in the production of MCP-1 in UT12-stimulated macrophages (Fig. 10b) in the LRT and production of MCP-1 in the lungs were induced after UT12 administration.
359
The disappearance of the benefit from UT12 mediated macrophage recruitment and
360
MCP-1 production were observed in macrophage-depleted mice, indicating that resident 361 macrophages may be responsible for producing MCP-1 after stimulation with UT12.
362
Our results also demonstrated that UT12 administration increased the 
388
In conclusion, the present study demonstrated that treatment with the TLR4 rates of mice (PR8: n=10, Sp: n=8, PR8+Sp: n=10, PR8+Sp+UT12: n=10). Statistical 543 significance was determined using the log-rank test. **P < 0.01. was performed 2 days after S. pneumoniae infection. Each group contained 7 mice.
556
Values represent means ± SD, *P < 0.05, **P < 0.01, n.s.; not significant. 
